Abstract
Production of SPARC/osteonectin/BM-40 was determined in mouse B16 melanoma clones BL6 and F10 (high metastatic) and Fl (low metastatic). SPARC was produced greater amount in BL6 and F10 than in Fl cells, showing a good agreement with their metastatic potentials. Moreover, SPARC production was not influenced by culture pH, even in the acidic conditions (≈pH 5.9). Although tumor tissues show often low pH due to excessive amount of acidic metabolites such as lactate, most studies have been done in neutral pH. High SPARC production in the acidic medium, therefore, is thought to be an important potential for tumor invasive behaviour.
Similar content being viewed by others
References
Termine JD, Kleinman HK, Whitson SW et al: Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26:99–105, 1981.
Mason IJ, Taylor A, Williams JG, et al: Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial cell ‘culture shock’ glycoprotein of Mr 43,000. EMBO J 5:1465–1472, 1986.
Mann K, Deutzmann R, Paulsson M, Timpl R: Solubilization of protein BM-40 from a basement membrane tumor with chelating agents and evidence for its identity with osteonectin and SPARC. FEBS Lett 218:167–172, 1987.
Bellahcene A, Castronovo V: Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 146:95–100, 1995.
Porte H, Chastre E, Prevot S, et al: Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int J Cancer 64:70–75, 1995.
Porte H, Triboulet JP, Kotelevets L, et al: Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. Clin Cancer Res 4:1375–1382, 1998.
Ledda F, Bravo AI, Adris S, et al. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J Invest Dermatol 108:210–214, 1997.
Massi D, Franchi A, Borgognoni L, et al: Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas. Hum Pathol 30:339–344, 1999.
Rempel SA, Golembieski M, Ge S, et al: SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. J Neuropathol Exp Neurol 57:1112–1121, 1998.
Rempel SA, Ge S, Gutierrez JA: SPARC: a potential diagnostic marker of invasive meningiomas. Clin Cancer Res 5:237–241, 1999.
Le Bail B, Faouzi S, Boussarie L, et al: Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J Pathol 189:46–52, 1999.
Ledda MF, Adris S, Bravo AI, et al: Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nature Med 3:171–176, 1997.
Tremble PM, Lane TF, Sage EH, Werb Z: SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol 121:1433–1444, 1993.
Shankavaram UT, De Witt DL, Funk SE, et al: Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol 173:327–334, 1997.
Gilles C, Bassuk JA, Pulyaeva H, et al: SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res 58:5529–5536, 1998.
Kato Y, Sakai N, Baba M, et al: Stimulation of motility of human renal cell carcinoma by SPARC/osteonectin/BM-40 associated with type IV collagen. Invasion Metastasis 18:105–114, 1999.
Jacob K, Webber M, Benayahu D, Kleinman HK: Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. Cancer Res 59:4453–4457, 1999.
Kato Y, Nakayama Y, Umeda M, Miyazaki K: Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J Biol Chem 267:11424–11430, 1992.
Kato Y, Ozono S, Shuin T, Miyazaki K: Slow induction of gelatinase B mRNA by acidic culture conditions in mouse metastatic melanoma cells. Cell Biol Int 20:375–377, 1996.
Martinez-Zaguilán R, Seftor EA, Seftor RE, et al: Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis 14:176–186, 1996.
Sasaki T, Gohring W, Mann K, et al: Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J Biol Chem 272:9237–9243, 1997.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by Public Trust Haraguchi Memorial Cancer Research Found, Japan.
Rights and permissions
About this article
Cite this article
Kato, Y., Frankenne, F., Noël, A. et al. High production of SPARC/osteonectin/BM-40 in mouse metastatic B16 melanoma cell lines. Pathol. Oncol. Res. 6, 24–26 (2000). https://doi.org/10.1007/BF03032654
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03032654